INTERNATIONAL PATENT: HIGHFIELD BIOPHARMACEUTICALS CORPORATION, 杭州高田生物医药有限公司 FILES APPLICATION FOR "T CELL-DIRECTED IMMUNOLIPOSOME AND USE THEREOF"

GENEVA, March 8 -- HIGHFIELD BIOPHARMACEUTICALS CORPORATION (2-202, Building 2, 658 BinAn Road, BinJiang DistrictHangzhou, Zhejiang 310051), 杭州高田生物医药有限公司 (中国浙江省杭州市滨江区滨安路658号2幢2楼202室) filed a patent application (PCT/CN2023/115857) for "T CELL-DIRECTED IMMUNOLIPOSOME AND USE THEREOF" on Aug 30, 2023. With publication no. WO/2025/043547, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...